PubMed=8459226; DOI=10.1084/jem.177.4.989; PMCID=PMC2190978
Anichini A., Maccalli C., Mortarini R., Salvi S., Mazzocchi A., Squarcina P., Herlyn M., Parmiani G.
Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients.
J. Exp. Med. 177:989-998(1993)

PubMed=9743519; DOI=10.1084/jem.188.6.1005; PMCID=PMC2212536
Lupetti R., Pisarra P., Verrecchia A., Farina C., Nicolini G., Anichini A., Bordignon C., Sensi M., Parmiani G., Traversari C.
Translation of a retained intron in tyrosinase-related protein (TRP) 2 mRNA generates a new cytotoxic T lymphocyte (CTL)-defined and shared human melanoma antigen not expressed in normal cells of the melanocytic lineage.
J. Exp. Med. 188:1005-1016(1998)

DOI=10.13130/grazia-giulia_phd2016-02-18
Grazia G.
Co-targeting of oncogenic and death receptors pathways in human melanoma: pre-clinical rationale for a pro-apoptotic and anti-angiogenic strategy.
Thesis PhD (2015); Universita degli studi di Milano; Milano; Italy

PubMed=25576923; DOI=10.18632/oncotarget.2995; PMCID=PMC4413617
Loria R., Bon G., Perotti V., Gallo E., Bersani I., Baldassari P., Porru M., Leonetti C., Di Carlo S., Visca P., Brizzi M.F., Anichini A., Mortarini R., Falcioni R.
Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells.
Oncotarget 6:2779-2793(2015)